Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03742895
Brief Title: Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)

First Submitted : November 14, 2018
First Submitted that Met QC Criteria : November 14, 2018
First Posted : November 15, 2018

Last Update Submitted that Met QC Criteria : February 21, 2020
Last Update Posted : February 24, 2020 (Estimate)